Integrating PET and Fluorescence Imaging with a Novel PSMA-ICG Conjugate for Prostate Cancer Management
Molecular Pharmaceutics · 01.06.2026 · 23 (6) · 3341-3352
DOI: 10.1021/acs.molpharmaceut.5c01950 ↗Kurz gefasst
Fachartikel in der Zeitschrift Molecular Pharmaceutics, online erschienen am 08.05.2026. Verfasst von Jiale Hou und 8 weiteren Autor:innen. Beteiligte Einrichtung: Department of Nuclear Medicine, Xiangya Hospital, Central South University, Changsha 410008, China. Hauptthemen laut MEDLINE: Prostatic Neoplasms, Optical Imaging, Glutamate Carboxypeptidase II, Positron-Emission Tomography. Die Arbeit nennt 44 Literaturangaben. Gefördert von: Natural Science Foundation of Hunan Province, National Postdoctoral Program for Innovative Talents, Science and Technology Program of Hunan Province.
Abstract (Originalsprache)
Kein Abstract verfügbar.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Nuclear Medicine, Xiangya Hospital, Central South University, Changsha 410008, China.
- Key Laboratory of Biological Nanotechnology of National Health Commission, Xiangya Hospital, Central South University, Changsha 410008, China.
- Department of Urology, Disorders of Prostate Cancer Multidisciplinary Team, Xiangya Hospital, Central South University, Changsha 410008, China.
- National Clinical Research Center for Geriatric Disorders (Xiangya), Xiangya Hospital, Central South University, Changsha 410008, China.
ORCID-Profile: Yongxiang Tang, Peng Liu, Shuo Hu
Förderung
- Natural Science Foundation of Hunan Province
- National Postdoctoral Program for Innovative Talents
- Science and Technology Program of Hunan Province
- National Natural Science Foundation of China
- Youth Science Foundation of Xiangya Hospital
- Natural Science Foundation of Changsha City
Zitieren
APA
Hou, J., Tang, L., Zhou, M., Yang, J., Tang, Y., Cai, Y., Yang, Y., Liu, P., & Hu, S. (2026). Integrating PET and Fluorescence Imaging with a Novel PSMA-ICG Conjugate for Prostate Cancer Management. Molecular Pharmaceutics, 23(6), 3341-3352. https://doi.org/10.1021/acs.molpharmaceut.5c01950
Vancouver
Hou J, Tang L, Zhou M, Yang J, Tang Y, Cai Y, et al. Integrating PET and Fluorescence Imaging with a Novel PSMA-ICG Conjugate for Prostate Cancer Management. Molecular Pharmaceutics. 2026;23(6):3341-3352. doi:10.1021/acs.molpharmaceut.5c01950
BibTeX
@article{Hou2026,
author = {Hou, Jiale and Tang, Liying and Zhou, Ming and Yang, Jinhui and Tang, Yongxiang and Cai, Yi and Yang, Yi and Liu, Peng and Hu, Shuo},
title = {Integrating PET and Fluorescence Imaging with a Novel PSMA-ICG Conjugate for Prostate Cancer Management},
journal = {Molecular Pharmaceutics},
year = {2026},
volume = {23},
number = {6},
pages = {3341--3352},
doi = {10.1021/acs.molpharmaceut.5c01950}
}
EUVIMED